Form 4: Orthopediatrics Director Mark Throdahl Increases Stake with Significant Stock Award

Sentiment:

Insider Transaction Report


Orthopediatrics Corp. Director Mark C. Throdahl has acquired 8,401 shares of common stock, increasing his direct beneficial ownership to 167,881 shares, including restricted stock awards.

Summary

  • Mark C. Throdahl, a Director of Orthopediatrics Corp. (KIDS), acquired 8,401 shares of common stock on May 23, 2025.
  • The acquisition was reported with a price of $0, indicating it was likely a stock grant or award rather than a cash purchase.
  • Following this transaction, Mr. Throdahl's direct beneficial ownership increased to 167,881 shares.
  • His total beneficial ownership also includes 22,497 shares held indirectly by a Trust.
  • The direct beneficial ownership figure of 167,881 shares includes 42,290 shares of restricted stock awards.

Sentiment

Score: 7

Explanation: The acquisition of shares by a director, especially as a grant, is generally a positive signal as it increases insider ownership and aligns management interests with shareholders. While not a direct cash purchase, it still represents an increase in stake.

Positives

  • Director Mark C. Throdahl acquired 8,401 shares of common stock, further aligning his interests with those of the shareholders.
  • The acquisition, likely a grant, demonstrates continued compensation and retention of key leadership within the company.

Future Outlook

NA

Industry Context

NA

Related Party Transactions

  • Director Mark C. Throdahl acquired 8,401 shares of common stock from Orthopediatrics Corp., which is considered a related party transaction as it involves an insider and the company.

Stakeholder Impact

  • Shareholders: Increased alignment of director's interests with shareholders due to increased stock ownership.
  • Management/Employees: The grant of shares to a director is a form of compensation and retention, potentially impacting morale and stability at the leadership level.

Key Dates

DateDescription
05/23/2025Date of transaction where Mark C. Throdahl acquired shares.
05/28/2025Date the Form 4 was signed by the Attorney-in-Fact for Mark C. Throdahl.

Keywords

Orthopediatrics Corp., KIDS, Mark C. Throdahl, Director, SEC Form 4, Insider Transaction, Stock Acquisition, Beneficial Ownership, Restricted Stock Award, Equity Compensation

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.